Unit of Pediatric Hematology and Oncology, Department of Pediatrics.
Department of Thoracic Surgery.
J Pediatr Hematol Oncol. 2022 Mar 1;44(2):e474-e478. doi: 10.1097/MPH.0000000000002203.
Thoracic air leak syndromes (TALS) are very rare among the noninfectious pulmonary complications (PCs). They can either be idiopathic or have several risk factors such as allogeneic hematopoietic stem cell transplantation (allo-HSCT), graft versus host disease and rarely pulmonary aspergillosis. We present a 14-year-old girl with hypoplastic myelodysplastic syndrome who developed graft versus host disease on day 60, TALS on day 150, bronchiolitis obliterans syndrome on day 300, pulmonary aspergillosis on day 400 and COVID-19 pneumonia on day 575 after allo-HSCT. This is the first report of a child who developed these subsequent PCs after allo-HSCT. Therefore, the manifestations of these unfamiliar PCs like TALS and COVID-19 pneumonia, and concomitant pulmonary aspergillosis with management options are discussed.
胸部气漏综合征(TALS)在非感染性肺部并发症(PCs)中非常罕见。它们可以是特发性的,也可以有几个危险因素,如异基因造血干细胞移植(allo-HSCT)、移植物抗宿主病,很少见的还有肺曲霉病。我们报告了一例 14 岁女性,患有发育不良性骨髓增生异常综合征,在 allo-HSCT 后第 60 天发生移植物抗宿主病,第 150 天发生 TALS,第 300 天发生闭塞性细支气管炎综合征,第 400 天发生肺曲霉病,第 575 天发生 COVID-19 肺炎。这是首例 allo-HSCT 后发生这些后续 PCs 的儿童病例报告。因此,我们讨论了这些不常见的 PCs(如 TALS 和 COVID-19 肺炎)以及同时发生的肺曲霉病的表现和管理选择。